MAY 05, 2022 10:00 AM PDT

Mapping study paves way for new treatments

A first of its kind study recently published in Nature Genetics that included 9,000 Americans of European or African ancestry has generated maps of DNA-to-protein links for both groups. Proteins play a critical role in cellular function, and changes in protein mechanisms—often regulated by DNA variations—can lead to disease. DNA-to-protein mapping could help explain differences in the rates of some diseases in the two groups and help researchers understand some health disparities.

Researchers have been mapping the molecular roots of human diseases for decades through so-called genetic mapping studies. The best known is the genome-wide association study (GWAS). A GWAS typically links variations in DNA to disease risk by analyzing the DNA of subjects—often tens or hundreds of thousands of individuals at a time—along with their history of a given disease. This uncovers statistical associations linking the disease to specific DNA variations.

Missing from the GWAS picture: Most of the disease-linked DNA variants identified by GWAS analysis do not lie within protein-coding genes. Researchers therefore assumed that many—even most—disease-linked DNA variants affect proteins indirectly, by regulating one or more steps in the gene-to-protein production process, thereby altering protein levels. Linking diseases directly to proteins, researchers can better understand the roots of disease—and also identify protein targets for disease prevention and treatments.

“This relatively new kind of mapping study provides a wealth of information that will allow researchers to test for potential links of proteins on various types of health outcomes—risk of cancers, heart disease, severe COVID—and help to develop or repurpose therapeutic drugs,” says study senior author Nilanjan Chatterjee, PhD, Bloomberg Distinguished Professor in the Department of Biostatistics at the Bloomberg School.

The analysis covered 7,213 Americans of European ancestry and 1,871 African Americans in the long-running Atherosclerosis Risk in Communities (ARIC) study, headed by Coresh; and 467 African Americans from the African American Study of Kidney Disease and Hypertension (AASK). In both of these studies, the research teams had sequenced the genomes of the participants and recorded bloodstream levels of thousands of distinct proteins. Chatterjee’s team and collaborators anticipate doing further studies in the ARIC and AASK cohorts, as well as in other diverse cohorts, to gather information on proteins and other factors that influence the DNA-to-disease chain of causality.

Sources: Nature Genetics

MS in Geological Sciences
Laurence Tognetti is a six-year USAF Veteran who earned both a BSc and MSc from the School of Earth and Space Exploration at Arizona State University. Laurence is extremely passionate about outer space and science communication, and is the author of “Outer Solar System Moons: Your Personal 3D Journey”.
You May Also Like
APR 22, 2022
Genetics & Genomics
Identifying "Cancer Culprits" in the Genome
APR 22, 2022
Identifying "Cancer Culprits" in the Genome
Most cells carry the complete genome in their nucleus, and as cells divide and age, they can pick up mutations in that g ...
MAY 11, 2022
Microbiology
A High-Fiber Diet Lowers Antibiotic Resistance in Gut Microbes
MAY 11, 2022
A High-Fiber Diet Lowers Antibiotic Resistance in Gut Microbes
There is debate about exactly what makes a diet healthy, but most experts can agree on some things, like the importance ...
JUN 27, 2022
Drug Discovery & Development
Potential Gene Targets Identified for Treating Deafness
JUN 27, 2022
Potential Gene Targets Identified for Treating Deafness
Researchers have identified three mutations of the MINAR2 gene that are linked to deafness. They say that the mutations ...
JUN 29, 2022
Microbiology
Unleashing the Genetic Power of Ocean Microbes
JUN 29, 2022
Unleashing the Genetic Power of Ocean Microbes
By analyzing over 1,000 samples of the marine environment, researchers have reconstructed the genomes of 25,000 novel mi ...
JUL 21, 2022
Clinical & Molecular DX
Best practices for lateral flow assay development
JUL 21, 2022
Best practices for lateral flow assay development
In our best practices blog, we explore how lateral flow assay design affects test performance. Read on to gain a deeper ...
AUG 15, 2022
Cell & Molecular Biology
Researchers Create the First Synthetic Mouse Embryo
AUG 15, 2022
Researchers Create the First Synthetic Mouse Embryo
Scientists have been able to create stem cells that can mimic the early stages of mouse development. The researchers use ...
Loading Comments...